全球肢端肥大症治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

全球肢端肥大症治疗市场需求预计将从 2023 年的 27.2 亿美元增加到 2032 年的近 47.1 亿美元，2024-2032 年研究期间CAGR为 6.28%。

肢端肥大症的治疗涉及解决生长激素 (GH) 产生过多和组织过度生长的问题，特别是手、脚和脸部的组织，这些组织与肢端肥大症有关。肢端肥大症通常是由脑下垂体良性过度生长引起的，导致 GH 分泌增加。

市场动态

肢端肥大症治疗市场是由肢端肥大症的识别、诊断和管理因素所推动的，肢端肥大症是一种罕见的内分泌疾病，其特征是生长激素分泌过多。在诊断技术进步的帮助下，医疗保健专业人员和公众的认识不断提高，可以儘早准确地识别病情。治疗方式的进步，包括新的药物和手术技术，有助于扩大可用的选择。涉及内分泌科医生、神经外科医生和医疗保健专业人员的多学科护理方法增强了患者的整体管理。全球医疗保健支出的增加、患者的倡导努力以及政府支持罕见疾病的倡议进一步推动了市场的发展。研究合作、参与临床试验以及全球老年人口的增加等因素促进了肢端肥大症治疗格局的持续发展。随着对肢端肥大症的了解不断深入，市场有望为诊断出患有这种罕见疾病的个人提供改进和客製化的治疗方案。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球肢端肥大症治疗市场的各个细分市场进行了包容性评估。肢端肥大症治疗产业的成长和趋势为本研究提供了整体方法。

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲肢端肥大症治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。肢端肥大症治疗市场的主要参与者包括诺华公司、易普森製药公司、太阳製药工业有限公司、Chiasma Inc.、Peptron Inc.、WOCKHARDT、Dauntless Pharmaceuticals、辉瑞公司、Ionis Pharmaceuticals, Inc.。查看竞争格局，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：肢端肥大症治疗 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按药物类型分類的市场吸引力分析
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球肢端肥大症治疗市场分析：依药物类型

• 按药物类型概述
• 历史和预测数据
• 依药物类型分析
• 生长抑素类似物
• GHRA
• 其他的

第 6 章：全球肢端肥大症治疗市场分析：依最终用途分类

• 按最终用途分類的概述
• 历史和预测数据
• 按最终用途分析
• 医院和诊所
• 其他的

第 7 章：全球肢端肥大症治疗市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 8 章：肢端肥大症治疗公司的竞争格局

• 肢端肥大症治疗市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 9 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Novartis AG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Ipsen Pharma
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Sun Pharmaceutical Industries LTD.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Chiasma Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Peptron Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• WOCKHARDT
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Dauntless Pharmaceuticals
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Pfizer Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Ionis Pharmaceuticals Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Acromegaly Treatment Market is presumed to reach the market size of nearly USD 4.71 BN by 2032 from USD 2.72 BN in 2023 with a CAGR of 6.28% under the study period 2024 - 2032.

Acromegaly treatment involves addressing the excessive production of growth hormone (GH) and the overgrowth of tissues, particularly in the hands, feet, and face, associated with the medical condition known as acromegaly. Acromegaly is typically caused by the benign overgrowth of the pituitary gland, leading to increased GH secretion.

MARKET DYNAMICS

The Acromegaly treatment market is driven by factors contributing to the recognition, diagnosis, and management of acromegaly, a rare endocrine disorder characterized by excessive growth hormone production. Increasing awareness among healthcare professionals and the general public, aided by advancements in diagnostic technologies, leads to early and accurate identification of the condition. Advances in treatment modalities, including novel medications and surgical techniques, contribute to the expansion of available options. The multidisciplinary care approach involving endocrinologists, neurosurgeons, and healthcare professionals enhances overall patient management. Rising healthcare expenditure globally, patient advocacy efforts, and government initiatives supporting rare diseases further drive the market. Collaboration in research, participation in clinical trials, and a global rise in the geriatric population, among other factors, contribute to the evolving landscape of Acromegaly treatment. As understanding of acromegaly progresses, the market is poised to offer improved and tailored treatment options for individuals diagnosed with this uncommon disorder.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of acromegaly treatment. The growth and trends of acromegaly treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the acromegaly treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Type

• Somatostatin Analogs
• GHRA
• Others

By End-Use

• Hospitals & Clinics
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Acromegaly Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Acromegaly Treatment market include Novartis AG, Ipsen Pharma, Sun Pharmaceutical Industries LTD., Chiasma Inc., Peptron Inc., WOCKHARDT, Dauntless Pharmaceuticals, Pfizer Inc., Ionis Pharmaceuticals, Inc.. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ACROMEGALY TREATMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Drug Type
  • 3.7.2 Market Attractiveness Analysis By End-use
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ACROMEGALY TREATMENT MARKET ANALYSIS BY DRUG TYPE

• 5.1 Overview by Drug Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Drug Type
• 5.4 Somatostatin analogs Historic and Forecast Sales by Regions
• 5.5 GHRA Historic and Forecast Sales by Regions
• 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL ACROMEGALY TREATMENT MARKET ANALYSIS BY END-USE

• 6.1 Overview by End-use
• 6.2 Historical and Forecast Data
• 6.3 Analysis by End-use
• 6.4 Hospitals & Clinics Historic and Forecast Sales by Regions
• 6.5 Others Historic and Forecast Sales by Regions

7 . GLOBAL ACROMEGALY TREATMENT MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE ACROMEGALY TREATMENT COMPANIES

• 8.1. Acromegaly Treatment Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF ACROMEGALY TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Novartis AG
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Ipsen Pharma
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Sun Pharmaceutical Industries LTD.
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Chiasma Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Peptron Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. WOCKHARDT
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Dauntless Pharmaceuticals
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Pfizer Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. Ionis Pharmaceuticals Inc.
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Drug Type (USD MN)
• Somatostatin analogs Market Sales by Geography (USD MN)
• GHRA Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by End-use (USD MN)
• Hospitals & Clinics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Acromegaly Treatment Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Acromegaly Treatment Report
• Market Research Process
• Market Research Methodology
• Global Acromegaly Treatment Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Drug Type
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Drug Type (USD MN)
• Somatostatin analogs Market Sales by Geography (USD MN)
• GHRA Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Hospitals & Clinics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.